- support
- info@evidentic.com
- +49 (0) 30 959 99 8831
Early breast cancer is a form of cancer that has not spread beyond the breast or the axillary lymph nodes. This includes ductal carcinoma in situ and can range from stage I to stage IIIA.
Showing all 2 results
ProductBatch | Antigen | Molecular Class | Drug Brand | Product Concentration | CoA | Quantity per vial | Storage Temperature | Expiry Date | Price from | |
---|---|---|---|---|---|---|---|---|---|---|
HER2 |
Monoclonal Antibody |
Perjeta® |
30 mg/mL |
yes |
6 mg |
-80°C |
11/2020 |
419,40 € |
||
HER2 |
Antibody-drug conjugate (ADC) |
Kadcyla® |
20 mg/mL |
– |
2 mg |
-80°C |
07/2023 |
348,30 € |
Evidentic GmbH
Martin-Buber-Str. 10
14163 Berlin